Phase 1, Open-Label, Randomized, Single-Dose, Crossover Bioequivalence And Food Effect Study For A New Formulation Of Premarin Compared With A Reference Tablet In Japanese Healthy Postmenopausal Women.
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2012
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Menopausal syndrome; Metrorrhagia; Vaginitis
- Focus Pharmacokinetics
- 14 Mar 2012 Actual end date (March 2012) added as reported by ClinicalTrials.gov.
- 14 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.